How to Treat High DHEA Sulfate Levels in Females

Treating high DHEA sulfate (DHEA-S) in females starts with identifying what is driving the excess, because the treatment differs substantially depending on the cause. The most common culprit is polycystic ovary syndrome (PCOS), but non-classic congenital adrenal hyperplasia, adrenal tumors, chronic stress, and even over-the-counter supplements can all push DHEA-S above normal range. Once the source is pinpointed, treatment typically involves some combination of oral contraceptives, anti-androgen medications, low-dose glucocorticoids, or lifestyle modifications, and in rare cases, surgery.

Why DHEA-S Levels Matter

DHEA-S is the sulfated form of dehydroepiandrosterone, a hormone produced almost exclusively by the adrenal glands. It serves as a precursor that the body converts into more potent androgens like testosterone. In the adrenal cortex, a specific zone called the zona reticularis churns out large quantities of DHEA thanks to a particular enzyme profile that favors its production.¹ Because the adrenals are the dominant source, a high DHEA-S reading on bloodwork points specifically to adrenal androgen overproduction rather than ovarian testosterone excess.

DHEA-S levels follow a predictable arc across a woman’s life. They peak somewhere around the late teens to mid-twenties and then decline steadily, falling to roughly 10–20% of peak values in older age.² One large cross-sectional study found that women’s DHEA-S peaked in the 15–19 age group and then dropped continuously through old age.³ So a “high” level needs to be interpreted relative to your age. A DHEA-S of 350 µg/dL in a 20-year-old woman might be mildly elevated, while the same number in a 50-year-old would be strikingly abnormal.

Figuring Out the Cause Before Treating

Treatment only makes sense once your doctor has sorted out why DHEA-S is elevated. The workup usually involves checking a panel of androgens (total and free testosterone, androstenedione, 17-hydroxyprogesterone), cortisol, prolactin, thyroid function, and insulin or glucose levels. If DHEA-S is extremely high, especially above roughly 600–700 µg/dL, imaging of the adrenal glands is warranted to rule out a tumor. A low-dose dexamethasone suppression test can help distinguish adrenal from ovarian sources of excess androgen and flag whether a tumor might be present.⁴

The most common causes break down as follows:

PCOS: The single most frequent reason for mildly to moderately elevated DHEA-S in premenopausal women. Up to half of women with PCOS who are not ovulating have elevated DHEA-S.⁵ Interestingly, non-classic PCOS phenotypes (those without the full combination of excess androgens, irregular periods, and polycystic ovaries) may actually have a higher rate of elevated DHEA-S than the classic, more severe phenotype.⁶
Non-classic congenital adrenal hyperplasia (NCAH): A genetic condition in which partial enzyme deficiency leads to normal cortisol but excessive adrenal androgens.⁷ About 95% of all congenital adrenal hyperplasia cases involve the 21-hydroxylase enzyme.⁸ Screening involves a morning 17-hydroxyprogesterone level, sometimes followed by an ACTH stimulation test.
Adrenal tumors: Rare, but they produce strikingly high DHEA-S. One reported case showed pre-operative levels around 700 µg/dL from a benign adrenal adenoma.⁹
Chronic stress: Sustained physical or psychological stress can raise DHEA-S output from the adrenals. Animal studies confirm that both acute restraint stress and prolonged stressors drive DHEA-S higher.¹⁰
Supplements and medications: Over-the-counter DHEA supplements, often marketed for anti-aging or libido, will directly raise DHEA-S blood levels.¹¹ Various pharmaceutical agents can also shift DHEA-S concentrations up or down through different mechanisms.¹²

Symptoms That Often Prompt Treatment

Most women seek help not because a lab number is out of range but because of the visible and disruptive effects of androgen excess. In a clinical study of women with PCOS, the most common skin-related findings were hirsutism (excess hair growth on the face and body) in about two-thirds of patients, acne in a similar proportion, and androgenic hair thinning in roughly half. Both hirsutism and acne showed a statistically significant correlation with DHEA-S levels specifically.¹³

Beyond skin and hair, there are mental health dimensions that often get overlooked. In adolescent girls, higher DHEA concentrations have been linked to increased anxiety symptoms, particularly generalized anxiety.¹⁴ Separately, in women with hirsutism, DHEA-S levels correlated positively with depression severity.¹⁵ Whether DHEA-S directly contributes to mood problems or whether the physical symptoms of androgen excess drive psychological distress (or both) remains unclear, but it is another reason to take elevated levels seriously rather than dismissing them as cosmetic.

Oral Contraceptives as First-Line Treatment

For most premenopausal women with mildly to moderately elevated DHEA-S, particularly from PCOS, combined oral contraceptives are the standard first step. The pill works on multiple fronts: the estrogen component boosts sex hormone-binding globulin (SHBG), which binds up free androgens and makes them inactive, while the progestin component suppresses both ovarian and adrenal androgen production.

Studies comparing different pill formulations show that low-dose oral contraceptives of various types all substantially reduce DHEA-S, testosterone, and other androgens. One trial found that all four formulations tested raised SHBG by roughly 250% and caused significant drops in DHEA-S along with testosterone and other androgens.¹⁶ A separate comparison in PCOS women specifically found that DHEA-S dropped by 20–50% across all formulations tested, with those containing drospirenone or chlormadinone acetate producing the greatest androgen reductions and the steepest rise in SHBG.¹⁷

The practical takeaway: if you are prescribed a birth control pill partly to manage androgen excess, formulations with anti-androgenic progestins (drospirenone is the most widely available) tend to do a somewhat better job at lowering androgens than older progestins. But all combined pills help, and the choice often comes down to what you tolerate best in terms of side effects.

Anti-Androgen Medications

When oral contraceptives alone are not enough to control symptoms like hirsutism, an anti-androgen is often added. These drugs block testosterone from acting at the hair follicle or skin level, or they reduce its conversion to the more potent form dihydrotestosterone. The main options include spironolactone, cyproterone acetate, and finasteride.¹⁸

Spironolactone is the most commonly used anti-androgen in the United States, partly because cyproterone acetate is not available there. In head-to-head comparisons, spironolactone outperformed finasteride for hirsutism, reducing hair-growth scores by about 42% over nine months compared with about 15% for finasteride.¹⁹ In another trial that also included cyproterone acetate, all three drugs reduced hirsutism scores by a similar amount (roughly 39%) at the end of treatment, but spironolactone maintained its effect better after the drugs were stopped.²⁰

Anti-androgens primarily treat the symptoms of excess androgens rather than lowering DHEA-S itself. They are almost always used alongside oral contraceptives because spironolactone, cyproterone acetate, and finasteride can all cause birth defects in a male fetus if you become pregnant while taking them. That combination of a pill plus spironolactone is probably the most common regimen prescribed to young women dealing with PCOS-related hirsutism and acne in clinical practice.

Low-Dose Glucocorticoids for Adrenal Sources

When elevated DHEA-S is clearly adrenal in origin, as in non-classic congenital adrenal hyperplasia, low-dose glucocorticoids can directly suppress the adrenal androgen production pathway. The idea is to provide just enough cortisol-like signal to calm the adrenal glands without causing the side effects of long-term steroid use.

Dexamethasone given at bedtime is one well-studied approach. A dose-response study found that most women achieved normal DHEA-S levels with remarkably small doses: 0.125 mg suppressed DHEA-S adequately in about a quarter of women, an additional half responded to 0.250 mg, and a further 20% needed 0.375 mg. These doses were well below what had previously been considered necessary and were not associated with significant side effects.²¹

Prednisone is another option. Research in hirsute women showed that low-dose prednisone suppressed DHEA and DHEA-S more readily than it suppressed cortisol, meaning the adrenal androgens are more sensitive to glucocorticoid feedback than the stress hormone itself.²² A separate study confirmed that women with elevated androgens who did not fully suppress during a short dexamethasone test normalized their androgen levels after one month on a reverse circadian regimen of prednisolone.⁴

The catch with glucocorticoids is that they require careful monitoring. Even low doses carry risks over years, including bone thinning, weight gain, and disrupted blood sugar. Most endocrinologists reserve this approach for women with confirmed adrenal enzyme defects like NCAH, or occasionally add it short-term when DHEA-S remains stubbornly high despite other treatments.

Diet, Weight Management, and Lifestyle

Lifestyle interventions do not directly suppress DHEA-S the way a pill does, but they can meaningfully shift the hormonal environment. A randomized trial tested a comprehensive dietary overhaul (high in whole grains, legumes, vegetables, and low in animal fat and refined carbohydrates) in postmenopausal women. Over about five months, the intervention group saw testosterone drop by roughly 20%, SHBG rise by about 25%, and the ratio of testosterone to SHBG (a measure of how much active androgen is circulating) improved in nearly all participants. The women also lost an average of about 4 kg. Fasting glucose and insulin response during a glucose tolerance test both improved compared with controls.²³

While that trial focused on testosterone and SHBG rather than DHEA-S specifically, the logic is sound: losing excess weight reduces insulin resistance, which in turn reduces one of the key drivers of ovarian and adrenal androgen overproduction in PCOS. Higher SHBG also means less of whatever androgens are circulating can actually reach tissues. For women whose elevated DHEA-S is part of a broader PCOS picture with insulin resistance, weight loss and dietary change are genuinely therapeutic rather than just generic wellness advice.

Exercise matters too, though the relationship is a bit nuanced. Regular moderate activity improves insulin sensitivity and can help with weight management. However, extremely intense or prolonged exercise, especially in the context of psychological stress, could theoretically push adrenal output higher given the stress-DHEA-S connection mentioned earlier. A balanced routine is the sensible target.

A Note on Metformin

Because PCOS is the most common driver of high DHEA-S, women often ask about metformin, which is widely used to treat insulin resistance in PCOS. Here, the evidence throws a curveball. While metformin improves many metabolic and hormonal markers in PCOS, one study in infertile PCOS women found that metformin pretreatment actually raised DHEA-S levels, even as other androgens were unaffected.²⁴ In a different context, prepubertal girls at risk for PCOS did show normalization of DHEA-S among other metabolic markers when treated with metformin.²⁵

The inconsistency likely reflects how differently metformin interacts with adrenal androgen pathways depending on age, weight, and the specific subtype of hormonal dysfunction involved. If your main concern is DHEA-S rather than testosterone or insulin, metformin may not be the right lever to pull, and your doctor should be aware that it could nudge DHEA-S in the wrong direction in some patients.

When Surgery Is the Answer

Surgery enters the picture when an adrenal tumor is the source. These are uncommon but unmistakable: DHEA-S levels are often dramatically elevated, and imaging reveals a mass on one of the adrenal glands. In the case report mentioned earlier, a woman with a benign adrenal adenoma had pre-operative DHEA-S around 700 µg/dL. After robotic-assisted laparoscopic adrenalectomy, her level dropped to 274 µg/dL within 19 hours and fell to 91 µg/dL by one month. Her scalp hair thickened after surgery, confirming that the tumor had been driving her androgen excess.⁹ A systematic review of benign androgen-producing adrenal tumors confirmed that surgery with biochemical normalization afterward is the standard approach for these cases.²⁶

The key signal for a possible tumor is a very high DHEA-S (often above 600–700 µg/dL), especially if it rises rapidly or is accompanied by sudden onset of virilizing symptoms like voice deepening, significant muscle bulk, or clitoral enlargement. These features demand urgent imaging and referral.

Stress Management and Psychological Interventions

Given the link between chronic stress and adrenal androgen output, stress reduction is not just a platitude here. A structured cognitive-behavioral stress management program studied in HIV-positive men (the best-designed trial on the topic, though not in women specifically) demonstrated that the intervention buffered against declines in DHEA-S and prevented increases in the cortisol-to-DHEA-S ratio, which the authors interpreted as a marker of healthier adrenal function under stress.²⁷

That particular study dealt with preserving DHEA-S in a context where it was falling rather than lowering it when elevated, so the evidence does not directly prove that stress management lowers abnormally high DHEA-S. But given that acute and chronic stress both raise adrenal DHEA-S output, and that anxiety and depression are associated with elevated DHEA-S in women, addressing stress is a reasonable part of a comprehensive plan, especially when an obvious adrenal or ovarian disease has been ruled out and the elevation is modest.

Putting a Treatment Plan Together

In practice, most treatment plans combine multiple strategies rather than relying on a single intervention. A woman with PCOS and moderately elevated DHEA-S might start with a combined oral contraceptive containing drospirenone, add spironolactone if hirsutism and acne persist after six months, and work on dietary changes and exercise to improve insulin sensitivity. A woman with non-classic congenital adrenal hyperplasia might need a low-dose glucocorticoid as the backbone of therapy, potentially combined with an anti-androgen for symptom relief. Someone taking a DHEA supplement simply needs to stop it.

Timelines matter for managing expectations. Oral contraceptives begin lowering androgen levels within a couple of months, but visible improvement in hirsutism takes at least six months because of how slowly the hair growth cycle turns over. Acne tends to respond faster. Anti-androgens similarly need months to show full effect on hair growth. The number on your lab report may normalize well before the mirror catches up.

Supplements That Claim to Lower DHEA-S

A quick internet search will turn up claims that supplements like spearmint tea, saw palmetto, reishi mushroom, or various herbal blends can lower androgen levels in women. While some small studies suggest spearmint tea may reduce free testosterone, the evidence is thin, and very few supplements have been rigorously tested for their effect on DHEA-S specifically. The appeal is understandable: these options feel gentler and more natural than prescription medications. But DHEA-S is produced deep in the adrenal glands, and it takes meaningful hormonal intervention to change that output. If your levels are genuinely elevated and causing symptoms, supplements are unlikely to be sufficient, and relying on them can delay effective treatment. That said, they probably do not hurt if used alongside proper medical therapy, and if spearmint tea makes you feel better, there is no reason not to drink it.

One supplement to actively watch out for is DHEA itself, which is sold over the counter in many countries. Women sometimes take it on the advice of anti-aging practitioners or wellness influencers without realizing it will directly raise the very hormone level they are trying to lower. If you have been told your DHEA-S is high, check your supplement shelf carefully: DHEA at even 50 mg per day will boost DHEA-S levels.¹¹

1
PubMed. Androgen synthesis in adrenarche
2
PubMed Central. A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?
3
The Journal of Clinical Endocrinology & Metabolism. Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood
4
The Journal of Clinical Endocrinology & Metabolism. The Value of the Low-Dose Dexamethasone Suppression Test in the Differential Diagnosis of Hyperandrogenism in Women
5
PubMed Central. Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia
6
PubMed Central. Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Years
7
PubMed Central. Nonclassic Congenital Adrenal Hyperplasia: What Do Endocrinologists Need to Know?
8
PubMed Central. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report
9
PubMed Central. Isolated DHEAS production by an adrenal neoplasm: Clinical, biochemical and pathologic characteristics
10
PubMed Central. Acute and chronic stress increase DHEAS concentrations in rhesus monkeys
11
PubMed. Dehydroepiandrosterone: a springboard hormone for female sexuality
12
PubMed. The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies
13
International Journal of Medical and Pharmaceutical Research. Cutaneous Manifestations and Their Relationship with Serum Testosterone and DHEAS Levels in Women with Polycystic Ovary Syndrome: A Cross‑Sectional Clinical Study
14
PubMed Central. Increased dehydroepiandrosterone (DHEA) is associated with anxiety in adolescent girls
15
Turkish Journal of Medical Sciences. Depression, anxiety, and their relation with clinical parameters and androgen levels in hirsute women
16
PubMed. Changes in androgens during treatment with four low-dose contraceptives
17
PubMed. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome
18
PubMed. Anti-androgens for the treatment of hirsutism
19
PubMed. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism
20
PubMed. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism
21
Journal of the American Academy of Dermatology. Treatment of androgenic disorders with dexamethasone: Dose-response relationship for suppression of dehydroepiandrosterone sulfate
22
The Journal of Clinical Endocrinology & Metabolism. Effect of Daily and Alternate Day Low Dose Prednisone on Serum Cortisol and Adrenal Androgens in Hirsute Women
23
Cancer Epidemiology, Biomarkers & Prevention. Reducing Bioavailable Sex Hormones through a Comprehensive Change in Diet: the Diet and Androgens (DIANA) Randomized Trial
24
PubMed. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome
25
The Journal of Clinical Endocrinology & Metabolism. Insulin Sensitization for Girls with Precocious Pubarche and with Risk for Polycystic Ovary Syndrome: Effects of Prepubertal Initiation and Postpubertal Discontinuation of Metformin Treatment
26
PubMed. Benign androgen-producing adrenal tumors: A systematic review of cases and case series
27
Elsevier / PubMed Central. Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men